Table 4

Baseline characteristics of study patients

CharacteristicEntire cohort (N = 23)Physical activity group (n = 11)Standard care group (n = 12)
Age, mean (SD), y 14.70 (2.32) 15.18 (2.04) 14.25 (2.56) 
Sex (female), n (%) 12 (52) 7 (63) 5 (42) 
BMI, mean (SD), kg/m2 28.28 (9.69) 29.83 (12.34) 26.86 (5.58) 
OW/obese, n (%) 15 (65.22) 6 (54.54) 9 (75) 
Clot burden at diagnosis occlusive, n, (%) 14 (60.87) 7 (63.64) 7 (58.33) 
VTE location, n (%)    
 DVT 17 (73.91) 8 (72.73) 9 (75) 
 PE 3 (13.04) 2 (18.18) 1 (8.335) 
 Concurrent DVT and PE 3 (13.04) 1 (9.09) 2 (16.67) 
D-dimer, ng/mL    
 At diagnosis, mean (SD) 5792.24 (7222.35) 5416.67 (6997.21) 8077.6 (8783.46) 
 At exit visit, mean (SD) 352.86 (96.32) 406.67 (118.65) 300 (103.57) 
 Pre-VTE PA score, mean (95% CI) 60 (40, 79.7) 66 (33.7, 98.9) 57 (34, 80.2) 
 QoL score at diagnosis, mean (95% CI) 67 (57.5, 76.5) 71 (56, 87) 64 (52, 76.5) 
 PTS at exit visit, n (%) 3 (20) 
CharacteristicEntire cohort (N = 23)Physical activity group (n = 11)Standard care group (n = 12)
Age, mean (SD), y 14.70 (2.32) 15.18 (2.04) 14.25 (2.56) 
Sex (female), n (%) 12 (52) 7 (63) 5 (42) 
BMI, mean (SD), kg/m2 28.28 (9.69) 29.83 (12.34) 26.86 (5.58) 
OW/obese, n (%) 15 (65.22) 6 (54.54) 9 (75) 
Clot burden at diagnosis occlusive, n, (%) 14 (60.87) 7 (63.64) 7 (58.33) 
VTE location, n (%)    
 DVT 17 (73.91) 8 (72.73) 9 (75) 
 PE 3 (13.04) 2 (18.18) 1 (8.335) 
 Concurrent DVT and PE 3 (13.04) 1 (9.09) 2 (16.67) 
D-dimer, ng/mL    
 At diagnosis, mean (SD) 5792.24 (7222.35) 5416.67 (6997.21) 8077.6 (8783.46) 
 At exit visit, mean (SD) 352.86 (96.32) 406.67 (118.65) 300 (103.57) 
 Pre-VTE PA score, mean (95% CI) 60 (40, 79.7) 66 (33.7, 98.9) 57 (34, 80.2) 
 QoL score at diagnosis, mean (95% CI) 67 (57.5, 76.5) 71 (56, 87) 64 (52, 76.5) 
 PTS at exit visit, n (%) 3 (20) 

CI, confidence interval; PA, physical activity.